What is the aim of this review?
This Cochrane Review aims to establish whether any evidence is available to support the current approach to contact tracing (the process of identifying individuals exposed to an infectious case of tuberculosis), and whether alternate options could result in a higher rate of infection detection in contacts. We searched for all relevant studies to answer this question.
Contact tracing is an important method to further reduce the rates of tuberculosis. Cochrane Review authors identified no studies addressing this question. Therefore further research is needed to determine whether alternate contact tracing approaches could produce a greater yield in the number of contacts detected and the proportion of individuals with disease.
What was studied in the review?
Tuberculosis (TB) is an infectious disease caused by Mycobacterium tuberculosis bacteria. Globally, tuberculosis infects an estimated 1.7 billion people, with 1.3 million deaths and 10 million new cases each year. Tuberculosis is transmitted via droplets coughed up from infected patients to susceptible contacts. The World Health Organization (WHO) aims to eliminate this disease by 2035. To achieve this ambitious task, the current decline in new cases must be at a faster rate. In high-income countries with low rates of tuberculosis, contact tracing is the primary method used to find those at risk of developing tuberculosis.
What are the main results of the review?
The review authors found that no suitable randomized controlled trials have been conducted to answer this question. There is insufficient high-certainty evidence comparing current contact tracing methods used against alternate options; further research is therefore needed.
How up-to-date is this review
We searched for studies published up to 15 July 2019.
This Cochrane Review highlights the lack of research in support of the current contact tracing method and the need for RCTs to compare new methods such as social network analysis to improve contact tracing processes.
Tuberculosis is an infectious bacterial disease that is spread via respiratory droplets from infected individuals to susceptible contacts. To eliminate this disease from low- and medium-incidence settings, people who are most likely to be infected (contacts) must be identified. Recently, study authors have examined alternate approaches to contact tracing methods that demonstrate improved detection and prioritization of contacts. The comparative benefit of these methods has not been established.
To assess the effectiveness of novel methods of contact tracing versus current standard of care to identify latent and active cases in low- to moderate-incidence settings.
We searched CENTRAL, MEDLINE, Embase, LILACS, Web of Science, and CINAHL up to 15 July 2019. We also searched for clinical trials and examined reference lists and conference proceedings.
Randomized controlled trials (RCTs) and cluster-RCTs of contact tracing strategies that included alternate approaches (other than standard practice).
Two review authors independently assessed identified articles for eligibility and quality using prespecified criteria.
No trials met the inclusion criteria of this review. Several study authors described an alternate method for examining contacts and performing social network analysis but did not compare this with the current contact tracing approach.